AnaptysBio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AnaptysBio Inc (ANAB)
AnaptysBio Inc stock price live, this page displays NASDAQ ANAB stock exchange data. View the ANAB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the AnaptysBio Inc real time stock price chart below.
What Is the AnaptysBio Inc Stock Price Today?
The AnaptysBio Inc stock price today is 47.89.
What Is the Stock Symbol for AnaptysBio Inc?
The stock symbol for AnaptysBio Inc is "ANAB."
What Stock Exchange Does AnaptysBio Inc Trade On?
AnaptysBio Inc is listed and trades on the NASDAQ stock exchange.
Is AnaptysBio Inc a Good Stock to Buy?
Determining whether AnaptysBio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANAB quote. (ISIN: US0327241065)
What Is the AnaptysBio Inc Stock Price Today?
The AnaptysBio Inc stock price today is 47.89.
What Is the Stock Symbol for AnaptysBio Inc?
The stock symbol for AnaptysBio Inc is "ANAB."
What Stock Exchange Does AnaptysBio Inc Trade On?
AnaptysBio Inc is listed and trades on the NASDAQ stock exchange.
Is AnaptysBio Inc a Good Stock to Buy?
Determining whether AnaptysBio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANAB quote. (ISIN: US0327241065)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
47.35
49.41
52 wk Range
29.48
73.30
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
47.3549.41
52 wk Range
29.4873.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(45.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(45.75%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANAB Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
87.25
Upside
+82.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- AnaptysBio Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Why is AnaptysBio stock rising afterhours today?- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 87.25
(+82.19% Upside)
Earnings
Latest Release
Sep 21, 2026
EPS / Forecast
5.11 / 5.11
Revenue / Forecast
27.49M / 27.49M
Compare ANAB to Peers and Sector
Metrics to compare | ANAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANABPeersSector | |
|---|---|---|---|---|
P/E Ratio | 4.1x | −0.8x | −0.3x | |
PEG Ratio | 0.00 | −0.04 | 0.00 | |
Price/Book | 135.3x | 3.1x | 2.6x | |
Price / LTM Sales | 13.5x | 5.2x | 3.0x | |
Upside (Analyst Target) | 82.2% | 226.9% | 58.5% | |
Fair Value Upside | Unlock | 21.3% | 7.1% | Unlock |
AnaptysBio, Inc. discovers and out-licenses therapeutic bodies in the United States. The company manages financial collaborations for Jemperli, a PD-1 antagonist for various solid tumor indications; and Quimilza, an IL-36R antagonist mAb, which has completed two registration-enabling global Phase 3 trials, and GEMINI-1 and GEMINI-2, evaluating the safety and efficacy of Quimilza in patients with generalized pustular psoriasis. It has a collaboration and exclusive license agreement with GSK plc to develop Jemperli as a monotherapy; and an exclusive license agreement with Vanda Pharmaceuticals Inc. for the development and commercialization of Quimilza. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the AnaptysBio (ANAB) Stock Price Today?
The AnaptysBio stock price today is 47.89 USD.
What Stock Exchange Does AnaptysBio Trade On?
AnaptysBio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for AnaptysBio?
The stock symbol for AnaptysBio is "ANAB."
Does AnaptysBio Pay Dividends? What’s The Current Dividend Yield?
The AnaptysBio dividend yield is 45.75%.
What Is the AnaptysBio Market Cap?
As of today, AnaptysBio market cap is 1.47B USD.
What Is AnaptysBio's Earnings Per Share (TTM)?
The AnaptysBio EPS (TTM) is 9.42.
When Is the Next AnaptysBio Earnings Date?
AnaptysBio will release its next earnings report on Nov 04, 2026.
From a Technical Analysis Perspective, Is ANAB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has AnaptysBio Stock Split?
AnaptysBio has split 0 times.
How Many Employees Does AnaptysBio Have?
AnaptysBio has 104 employees.
What is the current trading status of AnaptysBio (ANAB)?
As of Oct 07, 2026, AnaptysBio (ANAB) is trading at a price of 47.89 USD, with a previous close of 49.20 USD. The stock has fluctuated within a day range of 47.35 USD to 49.41 USD, while its 52-week range spans from 29.48 USD to 73.30 USD.
What Is AnaptysBio (ANAB) Price Target According to Analysts?
The average 12-month price target for AnaptysBio is 87.25 USD, with a high estimate of 140 USD and a low estimate of 60 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +82.19% Upside potential.
What Is the ANAB Premarket Price?
ANAB's last pre-market stock price is 50.78 USD. The pre-market share volume is 1,310.00, and the stock has decreased by 1.58, or 3.21%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.